CLINICAL TRIALS PROFILE FOR MISOPROSTOL
✉ Email this page to a colleague
All Clinical Trials for misoprostol
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00097123 ↗ | RCT of Misoprostol for Postpartum Hemorrhage in India | Completed | Bill and Melinda Gates Foundation | N/A | 2002-09-01 | Death rates for pregnant women in rural India are approximately forty-five times higher than in the United States. Bleeding after the birth of a child and underlying anemia are the primary causes of mothers' deaths and sickness in rural India. This study assesses the effectiveness of an oral drug, misoprostol, given in the late stage of labor to reduce the incidence of maternal bleeding following births assisted by midwives in selected sites in Belgaum District, Karnataka, India. |
| NCT00097123 ↗ | RCT of Misoprostol for Postpartum Hemorrhage in India | Completed | Fogarty International Center of the National Institute of Health | N/A | 2002-09-01 | Death rates for pregnant women in rural India are approximately forty-five times higher than in the United States. Bleeding after the birth of a child and underlying anemia are the primary causes of mothers' deaths and sickness in rural India. This study assesses the effectiveness of an oral drug, misoprostol, given in the late stage of labor to reduce the incidence of maternal bleeding following births assisted by midwives in selected sites in Belgaum District, Karnataka, India. |
| NCT00097123 ↗ | RCT of Misoprostol for Postpartum Hemorrhage in India | Completed | Global Network for Women's and Children's Health Research | N/A | 2002-09-01 | Death rates for pregnant women in rural India are approximately forty-five times higher than in the United States. Bleeding after the birth of a child and underlying anemia are the primary causes of mothers' deaths and sickness in rural India. This study assesses the effectiveness of an oral drug, misoprostol, given in the late stage of labor to reduce the incidence of maternal bleeding following births assisted by midwives in selected sites in Belgaum District, Karnataka, India. |
| NCT00097123 ↗ | RCT of Misoprostol for Postpartum Hemorrhage in India | Completed | Jawaharlal Nehru Medical College | N/A | 2002-09-01 | Death rates for pregnant women in rural India are approximately forty-five times higher than in the United States. Bleeding after the birth of a child and underlying anemia are the primary causes of mothers' deaths and sickness in rural India. This study assesses the effectiveness of an oral drug, misoprostol, given in the late stage of labor to reduce the incidence of maternal bleeding following births assisted by midwives in selected sites in Belgaum District, Karnataka, India. |
| NCT00097123 ↗ | RCT of Misoprostol for Postpartum Hemorrhage in India | Completed | John E. Fogarty International Center (FIC) | N/A | 2002-09-01 | Death rates for pregnant women in rural India are approximately forty-five times higher than in the United States. Bleeding after the birth of a child and underlying anemia are the primary causes of mothers' deaths and sickness in rural India. This study assesses the effectiveness of an oral drug, misoprostol, given in the late stage of labor to reduce the incidence of maternal bleeding following births assisted by midwives in selected sites in Belgaum District, Karnataka, India. |
| NCT00097123 ↗ | RCT of Misoprostol for Postpartum Hemorrhage in India | Completed | National Cancer Institute (NCI) | N/A | 2002-09-01 | Death rates for pregnant women in rural India are approximately forty-five times higher than in the United States. Bleeding after the birth of a child and underlying anemia are the primary causes of mothers' deaths and sickness in rural India. This study assesses the effectiveness of an oral drug, misoprostol, given in the late stage of labor to reduce the incidence of maternal bleeding following births assisted by midwives in selected sites in Belgaum District, Karnataka, India. |
| NCT00097123 ↗ | RCT of Misoprostol for Postpartum Hemorrhage in India | Completed | National Center for Complementary and Integrative Health (NCCIH) | N/A | 2002-09-01 | Death rates for pregnant women in rural India are approximately forty-five times higher than in the United States. Bleeding after the birth of a child and underlying anemia are the primary causes of mothers' deaths and sickness in rural India. This study assesses the effectiveness of an oral drug, misoprostol, given in the late stage of labor to reduce the incidence of maternal bleeding following births assisted by midwives in selected sites in Belgaum District, Karnataka, India. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for misoprostol
Condition Name
Clinical Trial Locations for misoprostol
Trials by Country
Clinical Trial Progress for misoprostol
Clinical Trial Phase
Clinical Trial Sponsors for misoprostol
Sponsor Name
